Modulation of cell fates and activities by diketo phthalazines
Patent Number: 6953799
Date of First Priority Issue: Wednesday October 30th, 2002
Date Issued: Thursday November 10th, 2005
Assignee: Bach Pharma, Inc. (North Andover, MA)
Inventors: Henry, Mark O. (North Andover, MA); Lynn, William S. (Hillsborough, NC)
From Class: Differentiation
Comments: No comments
This patent teaches ways of modulating "stress" in cells through administration of "therapeutically effective amount of a phthalazine dione" in its one independent claim. The Assignee company, Bach Pharma, Inc is currently practicing the patent in the form of a registered drug (in Russia), Galavit® whose chemically active substance is Monosodium 5-Amino- 2-3-Dihydro-1-4-Phthalazine Dione.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.